Brooks Michael J Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$89,262.25
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Brooks Michael J

According to the SEC Form 4 filings, Brooks Michael J, being in a position of

  1. President at Edesa Biotech, Inc.,
    оver the last 12 months, has bought 2000 shares for $3,140, and sold 0 shares,
    over all time since 2020-01-08, has bought 29154 shares for $92,402, and sold 0 shares.

Biography of Brooks Michael J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $3,1401100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-02-26PurchaseEdesa Biotech, Inc.
EDSA
President
2,000
0.0243%
$1.57$3,140+264.52%
2022-06-29PurchaseEdesa Biotech, Inc.
EDSA
President
3,000
0.0196%
$1.49$4,483-22.3%
2022-06-16PurchaseEdesa Biotech, Inc.
EDSA
President
3,000
0.0189%
$1.61$4,817-24.24%
2022-05-25PurchaseEdesa Biotech, Inc.
EDSA
President
3,500
0.0226%
$1.74$6,090-19.54%
2022-03-14PurchaseEdesa Biotech, Inc.
EDSA
President
1,250
0.0092%
$2.79$3,487-37.87%
2022-03-10PurchaseEdesa Biotech, Inc.
EDSA
President
1,000
0.0074%
$3.22$3,223-46.35%
2022-03-08PurchaseEdesa Biotech, Inc.
EDSA
President
1,250
0.0091%
$2.90$3,622-40.56%
2021-03-25PurchaseEdesa Biotech, Inc.
EDSA
President
3,500
0.0303%
$5.19$18,165+7.18%
2021-03-24PurchaseEdesa Biotech, Inc.
EDSA
President
4,500
0.0401%
$5.08$22,860+12.65%
2020-05-27PurchaseEdesa Biotech, Inc.
EDSA
President
2,500
0.0282%
$3.00$7,499+89.33%
2020-01-08PurchaseEdesa Biotech, Inc.
EDSA
President
3,654
0.0545%
$4.11$15,018+53.65%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.